FundedIQ
Biotechnology

SHINE Technologies: Funding, Investors & Team (Oct 2026)

SHINE deploys its safe, cost-effective, and environmentally friendly fusion technology in a stepwise approach. Its systems are used to inspect industrial components in aerospace, defense, energy, and other sectors. SHINE’s proprietary medical isotope production processes create molybdenum-99 and non-carrier-added lutetium-177. These important medicines are used in tens of thousands of daily procedures to diagnose and treat heart disease, late-stage cancer, and other serious illnesses. In the future, SHINE plans to scale its fusion technology to help solve one of the energy’s toughest hurdles by recycling nuclear waste. Through a purpose-driven and phased approach, SHINE aims to generate fusion power to deliver clean, abundant energy that could transform life on Earth.

www.shinefusion.com LinkedIn Janesville, United States 251-500 employees
Total raised
$605M
Rounds
6
Latest
Undisclosed round
Apr 2026

SHINE Technologies has raised $605M across 6 funding rounds on record, the most recent an undisclosed round of $263M announced in Apr 2026.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

SHINE Technologies Company Profile and Key Stats

Total funding raised
$605M
across 6 rounds on record
Funding rounds on record
6
2 with no disclosed amount
Latest funding round
Undisclosed round
$263M in Apr 2026
Employees
251-500
reported band
Headquarters
Janesville, United States

Latest funding round on record: Apr 2026.

SHINE Technologies Funding Rounds

Date
Round
Amount
Undisclosed round
$263M
Undisclosed round
$240M
Undisclosed round
Undisclosed
Undisclosed round
Undisclosed
Undisclosed round
$32.0M
Undisclosed round
$70.0M

2 of 6 rounds were announced without a disclosed amount and are excluded from the total.

SHINE Technologies raised $70.0M in an undisclosed round announced in Oct 2023.

9 months later, an undisclosed round of $32.0M was announced in Jul 2024.

3 months later, an undisclosed round was announced in Oct 2024 with no disclosed amount.

4 months later, an undisclosed round was announced in Feb 2025 with no disclosed amount.

1 years later, an undisclosed round of $240M was announced in Feb 2026.

2 months later, an undisclosed round of $263M was announced in Apr 2026.

SHINE Technologies Founders and Leadership Team

Name
Role
Contact
Greg Piefer
Founder
Locked
Gregory Piefer
Founder
—
Hitesh Panchal
Founder
—

Contact details for the SHINE Technologies team: 1 of 3 have an email address on file.

Start 14-day free trial →

SHINE Technologies Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,148
$7.5M

SHINE Technologies' latest round of $263M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like SHINE Technologies in Biotechnology and Janesville

Companies Similar to SHINE Technologies

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…

Private Equity —

SHINE Technologies Funding FAQs

What does SHINE Technologies do?

SHINE deploys its safe, cost-effective, and environmentally friendly fusion technology in a stepwise approach. Its systems are used to inspect industrial components in aerospace, defense, energy, and other sectors. SHINE’s proprietary medical isotope production processes create molybdenum-99 and non-carrier-added lutetium-177. These important medicines are used in tens of thousands of daily procedures to diagnose and treat heart disease, late-stage cancer, and other serious illnesses. In the future, SHINE plans to scale its fusion technology to help solve one of the energy’s toughest hurdles by recycling nuclear waste. Through a purpose-driven and phased approach, SHINE aims to generate fusion power to deliver clean, abundant energy that could transform life on Earth.

How much funding has SHINE Technologies raised?

SHINE Technologies has raised $605M across 6 rounds on record. The most recent is an undisclosed round of $263M announced in Apr 2026.

When did SHINE Technologies last raise funding?

SHINE Technologies' most recent funding round on record is an undisclosed round of $263M, announced in Apr 2026.

Who founded SHINE Technologies?

FundedIQ lists Greg Piefer (Founder), Gregory Piefer (Founder), Hitesh Panchal (Founder) at SHINE Technologies.

Where is SHINE Technologies headquartered?

SHINE Technologies is based in Janesville, Wisconsin, United States.

How many employees does SHINE Technologies have?

SHINE Technologies is in the 251-500 employee band.

How does SHINE Technologies' funding compare to other Biotechnology startups?

SHINE Technologies' latest round of $263M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's SHINE Technologies Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SHINE Technologies is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.